Search Count: 12
 |
Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) In Complex With An Inhibitor Meds765
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2024-08-21 Classification: OXIDOREDUCTASE Ligands: NAP, A1ICG, EDO, MES |
 |
Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) In Complex With An Inhibitor M689, With The 3-Hydroxy-Benzoisoxazole Moiety. Resolution 2.0A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-03-06 Classification: OXIDOREDUCTASE Ligands: NAP, YMC, EDO |
 |
Crystal Structure Of Human Dihydroorotate Dehydrogenase In Complex With The Inhibitor 2-Hydroxy-N-(2-Ispropyl-5-Methyl-4-Phenoxyphenyl)Pyrazolo[1,5-A]Pyridine-3-Carboxamide.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-10-12 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, IEQ, P6G, ACT |
 |
Crystal Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) Complexed With Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2019-05-08 Classification: OXIDOREDUCTASE Ligands: NAP, FFW, EDO |
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase (Dhodh) Co-Crystallized With 3-Hydroxy-1-Methyl-5-((3-(Trifluoromethyl)Phenoxy)Methyl)-1H-Pyrazole-4-Carboxylic Acid
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-12-19 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, E2N |
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase (Dhodh) Co-Crystallized With N-(2,2-Diphenylethyl)-4-Hydroxy-1,2,5-Thiadiazole-3-Carboxamide
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-12-19 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, DZB |
 |
Targeting Myeloid Differentiation Using Potent Human Dihydroorotate Dehydrogenase (Hdhodh) Inhibitors Based On 2-Hydroxypyrazolo[1,5-A]Pyridine Scaffold
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2018-07-11 Classification: OXIDOREDUCTASE Ligands: DUH, CL, FMN, ACT, ORO, GOL, PGE |
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: NAP, CJ2 |
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: CVN, CL, NAP |
 |
Crystal Structure Of Potent Human Dihydroorotate Dehydrogenase Inhibitors Based On Hydroxylated Azole Scaffolds
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2017-03-08 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, HYT, ACT, CL |
 |
Crystal Structure Of Potent Human Dihydroorotate Dehydrogenase Inhibitors Based On Hydroxylated Azole Scaffolds
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2017-03-08 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, Y9B, ACT, CL |
 |
Crystal Structure Of Potent Human Dihydroorotate Dehydrogenase Inhibitors Based On Hydroxylated Azole Scaffolds
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2017-03-08 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, U91, ACT, CL |